Inventor
KAZMIERSKI WIESLAW MIECZYSLAW
US21 patents
⚠️ This page may combine multiple inventors who share the name “KAZMIERSKI WIESLAW MIECZYSLAW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXOSMITHKLINE IP DEV LTD
7 patentsUS10358427B2Jul 23, 2019
Modulators of indoleamine 2,3-dioxygenase
GLAXOSMITHKLINE IP DEV LTD11 citations81
US10899754B2Jan 26, 2021
Modulators of indoleamine 2,3-dioxygenase
GLAXOSMITHKLINE IP DEV LTD0 citations61
US10906924B2Feb 2, 2021
Modulators of indoleamine 2,3-dioxygenase
GLAXOSMITHKLINE IP DEV LTD0 citations60
US10538495B2Jan 21, 2020
Modulators of indoleamine 2,3-dioxygenase
GLAXOSMITHKLINE IP DEV LTD0 citations51
US10239894B2Mar 26, 2019
Inhibitors of indoleamine 2,3-dioxygenase
GLAXOSMITHKLINE IP DEV LTD0 citations51
US10927078B2Feb 23, 2021
Modulators of indoleamine 2,3-dioxygenase
GLAXOSMITHKLINE IP DEV LTD0 citations50
US10787442B2Sep 29, 2020
Modulators of indoleamine 2,3-dioxygenase
GLAXOSMITHKLINE IP DEV LTD0 citations49
SMITHKLINE BEECHAM CORP
7 patentsUS7645771B2Jan 12, 2010
CCR5 antagonists as therapeutic agents
SMITHKLINE BEECHAM CORP16 citations76
US7271172B2Sep 18, 2007
Pyrrolidine and azetidine compounds as CCR5 antagonists
SMITHKLINE BEECHAM CORP3 citations62
US7589207B2Sep 15, 2009
Cyclohexyl compounds as CCR5 antagonists
SMITHKLINE BEECHAM CORP2 citations61
US7589204B2Sep 15, 2009
Indane compounds as CCR5 antagonists
SMITHKLINE BEECHAM CORP0 citations50
US7531661B2May 12, 2009
Indane compounds as CCR5 antagonists
SMITHKLINE BEECHAM CORP0 citations50
US7569579B2Aug 4, 2009
Cyclopropyl compounds as ccr5 antagonists
SMITHKLINE BEECHAM CORP0 citations48
US7452992B2Nov 18, 2008
Heterocyclic compounds as CCR5 antagonists
SMITHKLINE BEECHAM CORP0 citations35